Massive european registry launches to unlock secrets of rare fat disorder
NCT ID NCT03553420
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a European registry for people with lipodystrophy, a rare condition where the body loses or lacks fat tissue. Researchers will follow up to 5,000 patients over time, collecting health data and genetic information. The goal is to better understand the disease, its progression, and how it affects patients, which could lead to improved care and future research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide crucial data to better understand lipodystrophy and improve care for patients.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly test any new therapy, so benefits for patients are indirect and long-term.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPODYSTROPHY ACQUIRED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP Nord Université de Paris, Hôpital Universitaire Robert-Debré
RECRUITINGParis, France
-
Abel Salazar Biomedical Sciences Institute - University of Porto
RECRUITINGPorto, Portugal
-
Academic Medical Center, University of Amsterdam
RECRUITINGAmsterdam, Netherlands
-
C. I. Parhon National Institute of Endocrinology, Bucharest, Romania
RECRUITINGBucharest, Romania
-
Department of Internal Medicine (Endocrinology and Nephrology), University of Leipzig
RECRUITINGLeipzig, Germany
-
Dept for Pediatrics and Adolescent Medicine, University of Ulm: Interdisciplinary obesity clinic
RECRUITINGUlm, 89075, Germany
-
Dokuz Eylul University School of Medicine
RECRUITINGIzmir, Turkey (Türkiye)
-
Endocrine Unit of University Hospital of Pisa
RECRUITINGPisa, Italy
-
Endocrinology Research Centre
RECRUITINGMoscow, Russia
-
Endocrinology Unit, Department of Clinical and Medical science, S. Orsola-Malpighi Hospital , University of Bologna
RECRUITINGBologna, Italy
-
Kinder-und Jugendkrankenhaus AUF DER BULT
RECRUITINGHanover, Germany
-
Lille University
RECRUITINGLille, France
-
Marmara University, Pediatric Endocrinology and Diabetes
RECRUITINGIstanbul, Turkey (Türkiye)
-
Med. Klinik B für Gastroenterologie und Hepatologie, Universitätsklinikum Münster
RECRUITINGMünster, 48149, Germany
-
Medical University of Vienna
RECRUITINGVienna, Austria
-
National Taiwan University Hospital
RECRUITINGTaipei, Taiwan
-
National and Kapodistrian University of Athens
RECRUITINGAthens, Greece
-
Palermo University
RECRUITINGPalermo, Italy
-
Pierre et Marie Curie School of Medicine, Sorbonne University
RECRUITINGParis, France
-
Policlinic University Hospital of Milan
RECRUITINGMilan, Italy
-
Santiago de Compostela University
RECRUITINGSantiago de Compostela, Spain
-
Second Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital
RECRUITINGAthens, Greece
-
Stoffwechselzentrum friendlydocs
RECRUITINGSankt Gallen, Switzerland
-
Tor Vergata University - Policlinico of Tor Vergata
RECRUITINGRoma, Italy
-
Universita del piemonte Orientale
RECRUITINGNovara, Italy
-
University Medical Center Ljubljana - Clinical Institute of Medical Genetics
RECRUITINGLjubljana, Slovenia
-
University of Cambridge Metabolic Research Laboratories
RECRUITINGCambridge, United Kingdom
-
University of Szeged, Department of Internal Medicine
RECRUITINGSzeged, Hungary
More trials for these conditions
Other studies related to the condition(s) this trial covers.